Gerresheimer AG (ETR:GXI – Get Free Report)’s stock price rose 1.4% during trading on Thursday . The stock traded as high as €75.95 ($82.55) and last traded at €75.40 ($81.96). Approximately 194,688 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 140,925 shares. The stock had previously closed at €74.35 ($80.82).
Gerresheimer Stock Performance
The company has a debt-to-equity ratio of 87.94, a current ratio of 0.80 and a quick ratio of 0.40. The stock has a fifty day moving average price of €75.46 and a two-hundred day moving average price of €78.80. The company has a market cap of $2.50 billion, a P/E ratio of 21.87, a PEG ratio of 0.82 and a beta of 0.94.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
See Also
- Five stocks we like better than Gerresheimer
- Trading Halts Explained
- MarketBeat Week in Review – 03/24 – 03/28
- Conference Calls and Individual Investors
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.